StockRunway.com continuously monitors and scans the markets for day trading and swing trading signals on NASDAQ, NYSE, AMEX, OTCBB and Pink Sheet companies for its free e-newsletter subscribers.
New York, NY -- (SBWIRE) -- 09/20/2013 -- StockRunway.com issues special report on – Octagon 88 Resources Inc(OTCMKTS:OCTX), OncoSec Medical Inc(OTCMKTS:ONCS), Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT), Advanced Cell Technology, Inc.(OTCMKTS:ACTC)
Octagon 88 Resources Inc(OTCMKTS:OCTX) stock is at $6.88, down -5.10 percent from its previous close of $7.25. The stock opened the session at $7.61 and touched its highest price point at $7.61. Stock’s lowest price point for the session stood at $6.20.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive with +36.24% during previous three months trade. Its recent trading volume was 142,401.00 shares in comparison to its usual trading volume of 62,815.00 shares. Octagon 88 Resources, Inc., a natural resource exploration stage company, focuses on acquiring, exploring, and developing oil and gas assets in the United States and Canada. The company was founded in 2008 and is based in Englberg, Switzerland.
Has OCTX Found The Bottom and Ready To Move Up? Find Out Here
OncoSec Medical Inc(OTCMKTS:ONCS) stock is at $0.258, up +2.42 percent from its previous close of $0.2519. Its today’s volume is 5.6 million shares in comparison to its usual trading volume of 2.16 million shares. The stock opened the session at $0.25 and touched its highest price point at $0.27.
Company’s lowest price point for the session stood at $0.25, and its 52 week price range stood at $0.18- $0.49. Its quarterly performance remained red with the percentage of -1.19, while its year to date performance showed that the stock advanced overall +17.27%. OncoSec Medical Incorporated designs, develops, and commercializes novel cancer therapeutic products in the United States. Its products combine proprietary electroporation delivery technology with a chemotherapeutic or novel DNA-based immunotherapeutics, known as OMS ElectroOncology.
For How Long ONCS’s Gloss will Attract Investors? Find out via this report
Provectus Pharmaceuticals, Inc.(OTCMKTS:PVCT) started its trading session with the price $0.88, and closed at price of $0.950 by scoring +13.71%. Previous 5 days graph demonstrated an optimistic move of +43.86%. Its quarterly performance remained green with the percentage of +43.86.Stocks of the company traded with total volume of 1.19 million shares while the average trading capacity remained334,318.00 shares. Day range of the stock was $0.87-$0.95. Provectus Pharmaceuticals, Inc., a development-stage pharmaceutical company, engages in developing pharmaceuticals for oncology and dermatology indications.
Will PVCT Continue To Move Higher? Find Out Here
Advanced Cell Technology, Inc.(OTCMKTS:ACTC) ended its day with the gaining stream with the gain of +3.46% and closed at the price of $0.0628 after opening at $0.06. Stock traded during its last trading session with the total traded volume of 7.69 million shares as compared to its average volume of 9.95 million shares.
During last 5 trades the stock jumped almost +2.95%, and during last one month it slipped with the percentage of -1.72.The company’s total market capitalization is $161.02 Million along with 2.56 Billion shares outstanding. Advanced Cell Technology, Inc., a biotechnology company, engages in the development and commercialization of human embryonic and adult stem cell technology in the field of regenerative medicine.
Why Should Investors Buy ACTC After The Recent Gain? Just Go Here and Find Out
StockRunway.com is an Elite Financial Stock website catering to individual investors, fund managers, investment bankers and equity analysts. Whether you're new to penny stocks or a seasoned veteran, you'll find all the information you will need right here! Our research is a remarkable educational tool for everyone to utilize.
Sign up TODAY and join the vast amount of investors already benefiting from the best free alerts from StockRunway's service today!
This report/release/advertisement is a commercial advertisement and is for general information purposes only. Never invest in any stock featured on our site, Press Releases or emails unless you can afford to lose your entire investment. The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: StockRunway.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever. Read our Full Disclaimer by visiting our website.
Read Our Full Disclaimer at: http://www.stockrunway.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)